D.O.
Smith Institute for Urology at Lenox Hill / Northwell Health
Northwell Health’s System Director for Prostate Cancer at the Cancer Institute
Vice Chair of Urology at Lenox Hill Hospital
Art Rastinehad, D.O., joined the faculty at Northwell Health in January 2020. He is Northwell Health’s System Director for Prostate Cancer at the Cancer Institute and the Vice Chair of Urology at Lenox Hill Hospital. He trained at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship trained in Urologic Oncology and Interventional Radiology. He has expertise in various interventional radiological and surgical techniques, including image-guided procedures, varicocele embolization, and prostate artery embolization. He is one of the founding executive board members of the Focal Therapy Society est 2019.
Dr. Rastinehad’s prostate cancer team has now incorporated state-of-the-art imaging to help visualize suspicious areas in the prostate for cancer. Dr. Rastinehad has also authored and implemented clinical trials of new techniques in the diagnosis and treatment of localized prostate cancer. In 2011, at Northwell Heath, he was the principal investigator for a Phase III clinical trial using MRI/Ultrasound fusion technology to improve prostate biopsy techniques. Using information from the prostate MRI, we can now target specific areas to diagnose better and quantify a patient’s prostate cancer. This was the first trial of this technology in the United States outside the National Institutes of Health.
This new clinical approach is helping to lay a foundation for the evaluation of a new technique, Focal Therapy, which only treats the diseased portion of the prostate. As of May 2016, Dr Rastinehad was the first to perform a gold nano-particle-directed ablation using a transperineal MR US Fusion-guided focal therapy system. His current research focuses on developing a new image-guided surgical platform to guide focal prostate cancer therapy (Advanced Annotation Platform).
Disclosure information not submitted.
Friday, May 13, 2022
9:00 AM – 12:00 PM
Friday, May 13, 2022
9:00 AM – 9:05 AM
Friday, May 13, 2022
9:05 AM – 9:20 AM
Friday, May 13, 2022
10:35 AM – 12:00 PM
Saturday, May 14, 2022
2:00 PM – 5:00 PM
Saturday, May 14, 2022
3:00 PM – 5:00 PM